 BURLINGAME, Calif., Sept. 06, 2022 GLOBE NEWSWIRE -- Corvus Pharmaceuticals, Inc. Corvus or the Company Nasdaq: CRVS, a clinical-stage biopharmaceutical company, today announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference, which is taking place September 12-14, 2022. The Company will conduct one-on-one meetings with investors at this conference and a pre-recorded corporate overview presentation by Richard A. Miller, M.D., president and chief executive officer of Corvus, will be available to play on-demand starting at 7:00 am ET on September 12. 